Guidance

Newborn outcomes project: data collection permission

Permission from the Confidentiality Advisory Group for newborn outcomes data collection: sickle cell and thalassaemia screening.

This publication was withdrawn on

This information has been replaced by our guide to ‘Patient confidentiality in NHS population screening programmes’.

Documents

[WITHDRAWN] Permission from Confidentiality Advisory Group on newborn outcomes data from haemoglobinopathy screening

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document is the formal approval from the Confidentiality Advisory Group. It gives permission to the the sickle cell and thalassaemia screening programme to collect named data to assess outcomes for babies and children under 5 with sickle cell disorders or thalassaemia.

Published 24 November 2014